|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
 |
|
|
|
|
|
BioCat 2002
DAY ONE AGENDA
| 7:45am - 8:45am |
Registration, Welcome Coffee & "Visit the Exhibits" |
| 8:45-9:00am |
Opening Remarks |
| 9:00-9:45am |
Keynote Address : Progress and Outlook for U.S. Bioenergy and Biobased Product Research over the Last Five Years, Mr. Douglas Kaempf, The Department of Energy
|
|
|
|
|
|
|
|
|
SESSION I:
The Industrial Challenge of Biocatalysis
Chairman: Dr. Marcel Wubbolts, DSM Fine Chemicals
| 9:45-10:15am |
Future Developments in Biocatalysis: from Multi Step to Metabolic Engineering,
Dr. Roel Bovenberg, DSM Anti-infectives
|
| 10:15-10:45am |
Process Development Challenges for Whole Cell Bioreductions, Dr. David Pollard, Merck & Co. Inc
|
| 10:45-11:15am |
Morning Break & "Visit the Exhibits" |
|
|
|
|
|
|
|
|
|
SESSION II:
The State of the Art in Industrial Enzymes
Chairman: Dr. Geoff Hazlewood, Diversa Corporation
| 11:15-11:45am |
Whole-cell Biocatalysts - Old Wheels with Novel Technology, Dr. Oliver May, Degussa AG
|
| 11:45-12:15pm |
Biodiversity, Libraries, Mutagenesis Techniques and New Developments, Dr. Dan Robertson, Diversa Corporation
|
| 12:15-1:45pm |
Group Luncheon
|
| 1:45-2:15pm |
New Applications of Enzymes in the Production of Specialty Chemicals, Prof. Andreas Bommarius, Georgia Institute of Technology
|
| 2:15-2:45pm |
New Lipases by Protein Engineering, Dr. Kim Borch, Novozymes
|
|
|
|
|
|
|
|
|
SESSION III:
BioCatalysis in Fine Chemicals
Chairman: Dr. Oliver May, Degussa AG
| 2:45-3:15pm |
Chemical vs. Enzymatic Production of Cephalosporin Antibiotics - Process Development of an Enzymatic Route using Recombinant D-Amino Oxidase and Glutaryl Amidase, Dr. Frank Zocher, Aventis Pharma Deutschland GmbH
|
| 3:15-3:45pm |
Afternoon Break & "Visit the Exhibits" |
| 3:45-4:15pm |
Oxidoreductases: Efficient Biocatalysts in the Production of Optically Active Fine Chemicals, Dr. Harald Groeger, Degussa AG
|
| 4:15-4:45pm |
Discovery and Development of Enzyme Families for Production of Chiral Intermediates, Dr. Mark J. Burk, Diversa Corporation
|
| 4:45-5:15pm |
Integration of Disciplines in Biocatalyst Process Development, Dr. Marcel Wubbolts,
DSM Fine Chemicals
|
| 5:30-7:00pm |
Evening Reception |
|
|
|
|
|
|
|
Click here for BioCat2002 Day Two Agenda
PLEASE NOTE: This program is accurate as of press time; substitutions may be required in the case of illness or other unforeseen circumstances. The Catalyst Group reserves the right to make these changes.
Back to BioCat2002 - Europe
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright ©2002 by The Catalyst Group, Inc., Catalyst Group Resources, Inc., and Catalyst Consultants Publishing. All rights reserved.
|
|
|
|
|
|
|
